Eastwood Bio-Medical Canada Inc Capital Reinvestment Ratio

Latest as of July 2021: 0.27x

Eastwood Bio-Medical Canada Inc capital reinvestment ratio. Eastwood Bio-Medical Canada Inc (EBM) has a Capital Reinvestment Ratio of 0.27x as of July 2021, meaning it reinvests 0% of its operating cash flow (CA$21.00K) in capital expenditures (CA$5.57K). Check cash flow reinvestment rate of Eastwood Bio-Medical Canada Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

CA$21.00K

CAD

Capital Expenditures

CA$5.57K

CAD

Data as of

Jul 2021

Most recent filing

Eastwood Bio-Medical Canada Inc Capital Reinvestment Ratio by Year (None–None)

Eastwood Bio-Medical Canada Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Eastwood Bio-Medical Canada Inc cash flow conversion.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow